首页 > 最新文献

Nursing Critical Care最新文献

英文 中文
Inhaled epoprostenol for acute respiratory distress syndrome 吸入依前列醇治疗急性呼吸窘迫综合征
Q4 Nursing Pub Date : 2018-07-01 DOI: 10.1097/01.CCN.0000534919.47806.75
Nicole Schroeder, Danielle R. Castiello, Laura A. Siemianowski
Abstract: Acute respiratory distress syndrome (ARDS) is associated with high rates of mortality. Inhaled nitric oxide and inhaled epoprostenol (iEPO) are inhaled pulmonary vasodilators used for adjunctive management in patients with severe ARDS. This article describes the safe and effective use of iEPO in patients with refractory hypoxemia.
摘要:急性呼吸窘迫综合征(ARDS)与高死亡率有关。吸入性一氧化氮和吸入性依前列醇(iEPO)是用于严重ARDS患者辅助治疗的吸入性肺血管舒张剂。本文介绍了iEPO在难治性低氧血症患者中的安全有效应用。
{"title":"Inhaled epoprostenol for acute respiratory distress syndrome","authors":"Nicole Schroeder, Danielle R. Castiello, Laura A. Siemianowski","doi":"10.1097/01.CCN.0000534919.47806.75","DOIUrl":"https://doi.org/10.1097/01.CCN.0000534919.47806.75","url":null,"abstract":"Abstract: Acute respiratory distress syndrome (ARDS) is associated with high rates of mortality. Inhaled nitric oxide and inhaled epoprostenol (iEPO) are inhaled pulmonary vasodilators used for adjunctive management in patients with severe ARDS. This article describes the safe and effective use of iEPO in patients with refractory hypoxemia.","PeriodicalId":19344,"journal":{"name":"Nursing Critical Care","volume":" ","pages":"6–13"},"PeriodicalIF":0.0,"publicationDate":"2018-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/01.CCN.0000534919.47806.75","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48757421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Implementation of an enhanced recovery after surgery program 加强术后恢复计划的实施
Q4 Nursing Pub Date : 2018-07-01 DOI: 10.1097/01.CCN.0000532368.48473.17
S. Pasternak, N. Schwab, Vickie Thun
Enhanced recovery after surgery (ERAS) is an iterative, multidisciplinary approach used to achieve improved surgical outcomes, such as decreasing length of hospitalization, complications, readmission rates, and overall cost, while improving patient care quality. These results are achieved when current evidence-based best practices are used to decrease practice variability and improve multidisciplinary team coordination. The idea for ERAS, or a “fasttrack” recovery program, was initially described in the 1990s, and the first widely used application of ERAS was in recovery from coronary artery bypass surgery.1 Over the last 20 plus years, the ERAS concept has expanded to many different services and surgeries. At the authors’ institution, the median total length of stay (LOS) for patients undergoing colorectal surgery was 6.4 days with a readmission rate of 21%. Evidencebased best practices were not being used with this patient population. A review of the literature indicated that this was an opportunity for improvement. There is a great deal of literature regarding ERAS in the colorectal surgery population, which guided the start of this new program. The literature indicated potential LOS reductions of 30% to 50% with similar reductions in complications, while reducing readmissions and cost.2 For these reasons, the authors piloted this ERAS program in the colorectal surgery division of general surgery and have since expanded it to gynecology-oncology, benign gynecology, urology, and spinal surgery (adults and pediatrics). This article reviews the implementation of a quality initiative and development of an ERAS program, called the ERAS pathway, as well as some of the challenges and successes the ERAS pathway has experienced, specifically from a nursing perspective.
{"title":"Implementation of an enhanced recovery after surgery program","authors":"S. Pasternak, N. Schwab, Vickie Thun","doi":"10.1097/01.CCN.0000532368.48473.17","DOIUrl":"https://doi.org/10.1097/01.CCN.0000532368.48473.17","url":null,"abstract":"Enhanced recovery after surgery (ERAS) is an iterative, multidisciplinary approach used to achieve improved surgical outcomes, such as decreasing length of hospitalization, complications, readmission rates, and overall cost, while improving patient care quality. These results are achieved when current evidence-based best practices are used to decrease practice variability and improve multidisciplinary team coordination. The idea for ERAS, or a “fasttrack” recovery program, was initially described in the 1990s, and the first widely used application of ERAS was in recovery from coronary artery bypass surgery.1 Over the last 20 plus years, the ERAS concept has expanded to many different services and surgeries. At the authors’ institution, the median total length of stay (LOS) for patients undergoing colorectal surgery was 6.4 days with a readmission rate of 21%. Evidencebased best practices were not being used with this patient population. A review of the literature indicated that this was an opportunity for improvement. There is a great deal of literature regarding ERAS in the colorectal surgery population, which guided the start of this new program. The literature indicated potential LOS reductions of 30% to 50% with similar reductions in complications, while reducing readmissions and cost.2 For these reasons, the authors piloted this ERAS program in the colorectal surgery division of general surgery and have since expanded it to gynecology-oncology, benign gynecology, urology, and spinal surgery (adults and pediatrics). This article reviews the implementation of a quality initiative and development of an ERAS program, called the ERAS pathway, as well as some of the challenges and successes the ERAS pathway has experienced, specifically from a nursing perspective.","PeriodicalId":19344,"journal":{"name":"Nursing Critical Care","volume":"13 1","pages":"40–45"},"PeriodicalIF":0.0,"publicationDate":"2018-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/01.CCN.0000532368.48473.17","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45989596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implantable transvenous cardioverter-defibrillators in adults 成人植入式经静脉心脏复律除颤器
Q4 Nursing Pub Date : 2018-05-01 DOI: 10.1097/01.CCN.0000529944.38466.AB
Destiny R Brady, C. Macleod
Ms. K, 59, has a history of type 2 diabetes, depression, heart failure (HF) with reduced ejection fraction (HFrEF), and renal insufficiency. Three months ago, she experienced a myocardial infarction (MI) that led to HF. Ms. K’s ejection fraction during her last hospitalization was 30%, and she is New York Heart Association (NYHA) functional class III. She was admitted for placement of an implantable cardioverter-defibrillator (ICD).
59岁的K女士有2型糖尿病、抑郁症、射血分数降低的心力衰竭和肾功能不全病史。三个月前,她经历了心肌梗死(MI),导致HF。K女士在最后一次住院期间的射血分数为30%,属于纽约心脏协会(NYHA)功能III级。她因植入植入式心律转复除颤器(ICD)而入院。
{"title":"Implantable transvenous cardioverter-defibrillators in adults","authors":"Destiny R Brady, C. Macleod","doi":"10.1097/01.CCN.0000529944.38466.AB","DOIUrl":"https://doi.org/10.1097/01.CCN.0000529944.38466.AB","url":null,"abstract":"Ms. K, 59, has a history of type 2 diabetes, depression, heart failure (HF) with reduced ejection fraction (HFrEF), and renal insufficiency. Three months ago, she experienced a myocardial infarction (MI) that led to HF. Ms. K’s ejection fraction during her last hospitalization was 30%, and she is New York Heart Association (NYHA) functional class III. She was admitted for placement of an implantable cardioverter-defibrillator (ICD).","PeriodicalId":19344,"journal":{"name":"Nursing Critical Care","volume":"13 1","pages":"34–38"},"PeriodicalIF":0.0,"publicationDate":"2018-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/01.CCN.0000529944.38466.AB","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49105380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Professional leadership assessment for critical care nurse leaders 重症护理护士领导的专业领导力评估
Q4 Nursing Pub Date : 2018-05-01 DOI: 10.1097/01.ccn.0000525933.96254.89
Susan M. Politsky
There are many ways for critical care nurse leaders to maximize the effectiveness of their roles. In healthcare, almost everything today is metricsdriven. But are metrics the only way nurse leaders should monitor their leadership assessment? The answer is no. Nursing, and critical care in particular, has many other tools that can provide a snapshot of leadership potential. This arsenal includes evaluation, which is the vehicle that nurse leaders should incorporate into their own self-appraisal to help identify strengths and opportunities to become even better nurse leaders.
重症监护护士领导有很多方法可以最大限度地发挥他们的作用。在医疗保健领域,如今几乎所有的事情都是由指标驱动的。但是,指标是护士领导监督其领导力评估的唯一方法吗?答案是否定的。护理,特别是重症护理,有许多其他工具可以提供领导潜力的快照。这包括评估,这是一种工具,护士领导应该将其纳入自己的自我评估,以帮助确定优势和机会,成为更好的护士领导。
{"title":"Professional leadership assessment for critical care nurse leaders","authors":"Susan M. Politsky","doi":"10.1097/01.ccn.0000525933.96254.89","DOIUrl":"https://doi.org/10.1097/01.ccn.0000525933.96254.89","url":null,"abstract":"There are many ways for critical care nurse leaders to maximize the effectiveness of their roles. In healthcare, almost everything today is metricsdriven. But are metrics the only way nurse leaders should monitor their leadership assessment? The answer is no. Nursing, and critical care in particular, has many other tools that can provide a snapshot of leadership potential. This arsenal includes evaluation, which is the vehicle that nurse leaders should incorporate into their own self-appraisal to help identify strengths and opportunities to become even better nurse leaders.","PeriodicalId":19344,"journal":{"name":"Nursing Critical Care","volume":"13 1","pages":"41–42"},"PeriodicalIF":0.0,"publicationDate":"2018-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/01.ccn.0000525933.96254.89","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44632504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sedation in the ICU: A mindful approach to achieving a balance ICU中的镇静:实现平衡的一种谨慎方法
Q4 Nursing Pub Date : 2018-05-01 DOI: 10.1097/01.CCN.0000529939.25897.77
Carrie L. Griffiths, Spencer J. Livengood, K. Hertel
Abstract: Patients receiving treatment in the ICU are frequently agitated and subject to pain, so they commonly require sedation. Management of these patients requires a strategic, interdisciplinary approach, including proper monitoring, appropriate sedative selection, and the use of nonpharmacologic interventions. Patient-focused sedation leads to an improvement in patient care and outcomes.
摘要:在重症监护室接受治疗的患者经常情绪激动和疼痛,因此他们通常需要镇静。这些患者的管理需要一种战略性的跨学科方法,包括适当的监测、适当的镇静剂选择和非药物干预的使用。以患者为中心的镇静可以改善患者护理和结果。
{"title":"Sedation in the ICU: A mindful approach to achieving a balance","authors":"Carrie L. Griffiths, Spencer J. Livengood, K. Hertel","doi":"10.1097/01.CCN.0000529939.25897.77","DOIUrl":"https://doi.org/10.1097/01.CCN.0000529939.25897.77","url":null,"abstract":"Abstract: Patients receiving treatment in the ICU are frequently agitated and subject to pain, so they commonly require sedation. Management of these patients requires a strategic, interdisciplinary approach, including proper monitoring, appropriate sedative selection, and the use of nonpharmacologic interventions. Patient-focused sedation leads to an improvement in patient care and outcomes.","PeriodicalId":19344,"journal":{"name":"Nursing Critical Care","volume":"13 1","pages":"28–33"},"PeriodicalIF":0.0,"publicationDate":"2018-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/01.CCN.0000529939.25897.77","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47480932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Electrolyte series: Sodium and chloride 电解液系列:钠和氯化物
Q4 Nursing Pub Date : 2018-05-01 DOI: 10.1097/01.CCN.0000532360.64613.10
A. Rowe
Abstract: Sodium and chloride are primarily responsible for fluid movement across the compartments of the body. Neurologic, hormonal, and renal factors combine to regulate sodium levels and preserve fluid volume homeostasis. This article covers the causes, signs and symptoms, and available treatments for the following sodium and chloride imbalances associated with morbidity and mortality in critically ill patients: hyponatremia, hypernatremia, hyperchloremia, and hypochloremia.
摘要:钠和氯主要负责身体各部分的液体运动。神经、激素和肾脏因素共同调节钠水平并保持液体体积稳态。本文介绍了以下与危重患者发病率和死亡率相关的钠和氯失衡的原因、体征和症状,以及可用的治疗方法:低钠血症、高钠血症、高氯血症和低氯血症。
{"title":"Electrolyte series: Sodium and chloride","authors":"A. Rowe","doi":"10.1097/01.CCN.0000532360.64613.10","DOIUrl":"https://doi.org/10.1097/01.CCN.0000532360.64613.10","url":null,"abstract":"Abstract: Sodium and chloride are primarily responsible for fluid movement across the compartments of the body. Neurologic, hormonal, and renal factors combine to regulate sodium levels and preserve fluid volume homeostasis. This article covers the causes, signs and symptoms, and available treatments for the following sodium and chloride imbalances associated with morbidity and mortality in critically ill patients: hyponatremia, hypernatremia, hyperchloremia, and hypochloremia.","PeriodicalId":19344,"journal":{"name":"Nursing Critical Care","volume":"13 1","pages":"20–27"},"PeriodicalIF":0.0,"publicationDate":"2018-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/01.CCN.0000532360.64613.10","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47785562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Hyperglycemia management in patients with acute ischemic stroke 急性缺血性脑卒中患者的高血糖治疗
Q4 Nursing Pub Date : 2018-05-01 DOI: 10.1097/01.CCN.0000532362.87484.62
R. Macintyre, M. Ciechanowski
Abstract: Hyperglycemia has been associated with poor outcomes in patients with acute ischemic stroke. Blood glucose management becomes critical during the acute period following an ischemic stroke. This article evaluates the latest evidence in hyperglycemia treatment for consideration in the acute ischemic stroke population.
摘要:高血糖与急性缺血性脑卒中患者的不良预后有关。在缺血性中风后的急性期,血糖管理变得至关重要。本文评估了高血糖治疗的最新证据,以供急性缺血性中风人群考虑。
{"title":"Hyperglycemia management in patients with acute ischemic stroke","authors":"R. Macintyre, M. Ciechanowski","doi":"10.1097/01.CCN.0000532362.87484.62","DOIUrl":"https://doi.org/10.1097/01.CCN.0000532362.87484.62","url":null,"abstract":"Abstract: Hyperglycemia has been associated with poor outcomes in patients with acute ischemic stroke. Blood glucose management becomes critical during the acute period following an ischemic stroke. This article evaluates the latest evidence in hyperglycemia treatment for consideration in the acute ischemic stroke population.","PeriodicalId":19344,"journal":{"name":"Nursing Critical Care","volume":"13 1","pages":"14–19"},"PeriodicalIF":0.0,"publicationDate":"2018-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/01.CCN.0000532362.87484.62","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46791724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Be an advocate 做一个倡导者
Q4 Nursing Pub Date : 2018-05-01 DOI: 10.1097/01.CCN.0000529938.18274.F4
Yehudis Appel
{"title":"Be an advocate","authors":"Yehudis Appel","doi":"10.1097/01.CCN.0000529938.18274.F4","DOIUrl":"https://doi.org/10.1097/01.CCN.0000529938.18274.F4","url":null,"abstract":"","PeriodicalId":19344,"journal":{"name":"Nursing Critical Care","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/01.CCN.0000529938.18274.F4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44349242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recognizing cerebral venous thrombosis in adults 成人脑静脉血栓的识别
Q4 Nursing Pub Date : 2018-04-01 DOI: 10.1097/01.CCN.0000532361.49366.04
Vincent M. Vacca
Cerebral venous thrombosis is an underrecognized but serious thrombotic disorder that affects cerebral veins and sinuses. Clinical presentation varies based on extent and location of thrombosis within the cerebral venous system, and can include headache, focal neurologic deficits, focal or generalized seizures, stroke, and coma. Diagnosis is confirmed by brain and cerebral vascular imaging. Treatment focuses on anticoagulation, and outcomes are generally favorable.1,2
脑静脉血栓形成是一种认识不足但严重的血栓性疾病,影响脑静脉和鼻窦。临床表现因脑静脉系统内血栓形成的程度和位置而异,可能包括头痛、局灶性神经功能缺损、局灶或全身性癫痫发作、中风和昏迷。诊断是通过大脑和大脑血管成像来确认的。治疗的重点是抗凝,结果通常是有利的。1,2
{"title":"Recognizing cerebral venous thrombosis in adults","authors":"Vincent M. Vacca","doi":"10.1097/01.CCN.0000532361.49366.04","DOIUrl":"https://doi.org/10.1097/01.CCN.0000532361.49366.04","url":null,"abstract":"Cerebral venous thrombosis is an underrecognized but serious thrombotic disorder that affects cerebral veins and sinuses. Clinical presentation varies based on extent and location of thrombosis within the cerebral venous system, and can include headache, focal neurologic deficits, focal or generalized seizures, stroke, and coma. Diagnosis is confirmed by brain and cerebral vascular imaging. Treatment focuses on anticoagulation, and outcomes are generally favorable.1,2","PeriodicalId":19344,"journal":{"name":"Nursing Critical Care","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/01.CCN.0000532361.49366.04","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43485413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multimodal analgesia in critical care 重症监护中的多模式镇痛
Q4 Nursing Pub Date : 2018-03-01 DOI: 10.1097/01.CCN.0000527222.11558.c3
Gayle McGlory, A. Davis, K. Kirksey
Abstract: Pain is one of the most common patient complaints in the critical care setting. Multimodal analgesia is increasingly supported by scientific evidence and should be the preferred mechanism for addressing pain with a combination of opioid, nonopioid, and adjuvant analgesics, and nonpharmacologic interventions. This article reviews the problems associated with monomodal analgesic administration, evidence-based methods for adequately assessing pain and implementing interventions, the use of multimodal pharmacology, complementary and alternative medicine, and nursing considerations for patients with acute pain.
摘要:疼痛是危重病患者最常见的主诉之一。多模态镇痛越来越多地得到科学证据的支持,应该成为阿片类、非阿片类、辅助镇痛和非药物干预联合治疗疼痛的首选机制。本文综述了与单模镇痛相关的问题,基于证据的方法来充分评估疼痛和实施干预措施,多模态药理学的使用,补充和替代医学,以及急性疼痛患者的护理注意事项。
{"title":"Multimodal analgesia in critical care","authors":"Gayle McGlory, A. Davis, K. Kirksey","doi":"10.1097/01.CCN.0000527222.11558.c3","DOIUrl":"https://doi.org/10.1097/01.CCN.0000527222.11558.c3","url":null,"abstract":"Abstract: Pain is one of the most common patient complaints in the critical care setting. Multimodal analgesia is increasingly supported by scientific evidence and should be the preferred mechanism for addressing pain with a combination of opioid, nonopioid, and adjuvant analgesics, and nonpharmacologic interventions. This article reviews the problems associated with monomodal analgesic administration, evidence-based methods for adequately assessing pain and implementing interventions, the use of multimodal pharmacology, complementary and alternative medicine, and nursing considerations for patients with acute pain.","PeriodicalId":19344,"journal":{"name":"Nursing Critical Care","volume":"13 1","pages":"18–23"},"PeriodicalIF":0.0,"publicationDate":"2018-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/01.CCN.0000527222.11558.c3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46784609","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Nursing Critical Care
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1